GLSI
Price
$9.20
Change
-$0.00 (-0.00%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
122.99M
56 days until earnings call
OBIO
Price
$3.39
Change
+$0.30 (+9.71%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
118.39M
Interact to see
Advertisement

GLSI vs OBIO

Header iconGLSI vs OBIO Comparison
Open Charts GLSI vs OBIOBanner chart's image
Greenwich LifeSciences
Price$9.20
Change-$0.00 (-0.00%)
Volume$335
Capitalization122.99M
Orchestra BioMed Holdings
Price$3.39
Change+$0.30 (+9.71%)
Volume$6.39K
Capitalization118.39M
GLSI vs OBIO Comparison Chart
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. OBIO commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a StrongBuy and OBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 17, 2025
Stock price -- (GLSI: $9.20 vs. OBIO: $3.09)
Brand notoriety: GLSI and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 42% vs. OBIO: 30%
Market capitalization -- GLSI: $122.99M vs. OBIO: $118.39M
GLSI [@Biotechnology] is valued at $122.99M. OBIO’s [@Biotechnology] market capitalization is $118.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, OBIO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 2 TA indicator(s) are bullish while OBIO’s TA Score has 5 bullish TA indicator(s).

  • GLSI’s TA Score: 2 bullish, 6 bearish.
  • OBIO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -4.76% price change this week, while OBIO (@Biotechnology) price change was -6.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.01%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +8.87%.

Reported Earning Dates

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-2.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($123M) and OBIO($118M) have the same market capitalization . GLSI YTD gains are higher at: -18.077 vs. OBIO (-22.750). GLSI has higher annual earnings (EBITDA): -16.75M vs. OBIO (-68.48M). OBIO has more cash in the bank: 49.9M vs. GLSI (2.75M). OBIO has higher revenues than GLSI: OBIO (2.89M) vs GLSI (0).
GLSIOBIOGLSI / OBIO
Capitalization123M118M104%
EBITDA-16.75M-68.48M24%
Gain YTD-18.077-22.75079%
P/E RatioN/AN/A-
Revenue02.89M-
Total Cash2.75M49.9M6%
Total DebtN/A16.4M-
TECHNICAL ANALYSIS
Technical Analysis
GLSIOBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
63%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
52%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
49%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 20 days ago
59%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
58%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HQIRX20.87-0.17
-0.81%
Hartford Equity Income R3
JDVCX15.77-0.14
-0.88%
JPMorgan Diversified C
GSPTX34.06-0.45
-1.30%
Goldman Sachs Large Cap Equity Inv
MLPSX84.84-1.24
-1.44%
ProFunds Mid Cap Value Svc
FWOAX16.44-0.79
-4.61%
Fidelity Advisor Women's Leadership A

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-2.85%
ABOS - GLSI
43%
Loosely correlated
-6.14%
XBIT - GLSI
41%
Loosely correlated
-4.35%
DNLI - GLSI
41%
Loosely correlated
-2.51%
GBIO - GLSI
40%
Loosely correlated
-3.63%
CLDX - GLSI
39%
Loosely correlated
+4.47%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XERS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-2.22%
XERS - OBIO
40%
Loosely correlated
-1.58%
ARWR - OBIO
38%
Loosely correlated
-2.96%
KALV - OBIO
38%
Loosely correlated
-0.99%
EYPT - OBIO
37%
Loosely correlated
+1.92%
GLSI - OBIO
37%
Loosely correlated
-2.85%
More